Evidence map›Paper›PMID 25368115›Full record

ArticleInfection and immunity2015

Impact of detergent on biophysical properties and immune response of the IpaDB fusion protein, a candidate subunit vaccine against Shigella species.

Xiaotong Chen, Shyamal P Choudhari, Francisco J Martinez-Becerra, Jae Hyun Kim, Nicholas E Dickenson, Ronald T Toth, Sangeeta B Joshi, Jamie C Greenwood, John D Clements, William D Picking and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. International journal of molecular sciences · 2024
    Review
  2. Article
  3. Development of themSphere · 2023
    Article
  4. Article
  5. Structurally Related Liposomes ContainingMolecular pharmaceutics · 2022
    Article
  6. Article
  7. Article
  8. Structural Insights ofFrontiers in cellular and infection microbiology · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Xiaotong ChenDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, Oklahoma, USA.
Shyamal P ChoudhariDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, Oklahoma, USA.
Francisco J Martinez-BecerraDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, Oklahoma, USA.
Jae Hyun KimDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas, USA.
Nicholas E DickensonDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, Oklahoma, USA.
Ronald T TothDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas, USA.
Sangeeta B JoshiDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas, USA.
Jamie C GreenwoodDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, Oklahoma, USA.
John D ClementsDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
William D PickingDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, Oklahoma, USA.
C Russell MiddaughDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas, USA.
Wendy L PickingDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, Oklahoma, USA wendy.picking@ku.edu.
Oklahoma State University · USUniversity of Kansas · USTulane University · US

Funding

The multiple states of IpaB Shigella type III secretionR01AI099489 · NIAID · UNIVERSITY OF KANSAS LAWRENCE · PI PICKING, WILLIAM D. · 2013 to 2017
$2.2M
Assessment of serotype-independent immunity elicited by Shigella T3SS proteins.R01AI113307 · NIAID · UNIVERSITY OF KANSAS LAWRENCE · PI PICKING, WENDY L. · 2014 to 2017
$1.5M
NIAID NIH HHS R01 AI099489NIAID NIH HHS R01 AI113307NIAID NIH HHS R01 AI99489
6 · The paper itself

Abstract

Shigella spp. are causative agents of bacillary dysentery, a human illness with high global morbidity levels, particularly among elderly and infant populations. Shigella infects via the fecal-oral route, and its virulence is dependent upon a type III secretion system (T3SS). Two components of the exposed needle tip complex of the Shigella T3SS, invasion plasmid antigen D (IpaD) and IpaB, have been identified as broadly protective antigens in the mouse lethal pneumonia model. A recombinant fusion protein (DB fusion) was created by joining the coding sequences of IpaD and IpaB. The DB fusion is coexpressed with IpaB's cognate chaperone, IpgC, for proper recombinant expression. The chaperone can then be removed by using the mild detergents octyl oligooxyethelene (OPOE) or N,N-dimethyldodecylamine N-oxide (LDAO). The DB fusion in OPOE or LDAO was used for biophysical characterization and subsequent construction of an empirical phase diagram (EPD). The EPD showed that the DB fusion in OPOE is most stable at neutral pH below 55 °C. In contrast, the DB fusion in LDAO exhibited remarkable thermal plasticity, since this detergent prevents the loss of secondary and tertiary structures after thermal unfolding at 90 °C, as well as preventing thermally induced aggregation. Moreover, the DB fusion in LDAO induced higher interleukin-17 secretion and provided a higher protective efficacy in a mouse challenge model than did the DB fusion in OPOE. These data indicate that LDAO might introduce plasticity to the protein, promoting thermal resilience and enhanced protective efficacy, which may be important in its use as a subunit vaccine.

Indexed as

AnimalsAntigens, BacterialBacterial ProteinsBacterial VaccinesChemical PhenomenaDetergentsHydrogen-Ion ConcentrationMiceProtein StabilityRecombinant Fusion ProteinsTemperatureAntigens, BacterialBacterial ProteinsBacterial VaccinesDetergentsipaB protein, ShigellaIpaD protein, Shigella flexneriRecombinant Fusion Proteins

Identifiers

PMID25368115
PMCPMC4288857
OpenAlexW2118843036

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.